<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus</title><FirstPage>10720</FirstPage><LastPage>10720</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Recent studies hypothesize that dyslipidemia can predict glycated hemoglobin (HbA1c) and could be important contributing factor to the pathogenesis of type 2 diabetes mellitus (DM2). Terefore, we aimed to evaluate the in?uence of lipidparameters on long?term glycemic control in DM2. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;A total of 275 sedentary DM2 (mean [±standarddeviation] age 60.6 [±10.0] years) who volunteered toparticipate in this cross?sectional study were enrolled. Anthropometric (bodyweight, body hight, and waist circumference), biochemical parameters (fasting glucose, HbA1c, lipid parameters, creatinine), aswell as blood pressure were obtained. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Total cholesterol (odds ratio [OR] =1.30, 95% confdence interval [CI] [1.02–1.66],&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.032), triglycerides (OR = 1.34, 95% CI (1.07–1.67), &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.010), and low density lipoprotein cholesterol (OR = 1.42, 95%CI [1.10–1.83], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.006) were the independent predictors of higher HBA1c, and as they increased by 1 mmol/L each, probabilitiesof higher HBA1c increased by 30%, 34%, and 42%, respectively. Low level of high?density lipoprotein cholesterol (HDL?c) was foundto be the independent predictor of higher HBA1c (OR = 0.44, 95% CI [0.20–0.67], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.039), and increase in HDL?c by 1 mmol/L,reduced the probability of higher HBA1c by 56%. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Unfavorable lipid profle can predict HbA1c level in DM2 patients.Early diagnosis of dyslipidemia, as well as its monitoring and maintaining good lipids control can be used as a preventive measurefor optimal long?term glycemic control.&lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10720</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10720/5567</pdf_url></Article></Articles>
